Keyword Search :
  • Recognition and Treatment of Pediatric Bipolar Disorder

    Robert L. Findling, MD, MBA (Chair), et al

    Do you find the diagnosis and treatment of pediatric bipolar disorder challenging? Read this CME supplement to learn about the phenomenology and differential diagnosis of bipolar disorder in children and adolescents as well as evidence-based pharmacologic and psychotherapeutic interventions.

    View Activity

  • Measuring and Managing Cognitive Impairment in Schizophrenia

    S. Charles Schulz, MD (Chair), et al

    Cognitive impairment is present in almost all patients with schizophrenia, yet it often receives less clinical attention than positive and negative symptoms. Find out about reliable rating scales and assessment measures that can help you identify and monitor cognitive impairment.

    View Activity

  • Recognizing and Managing Insomnia in Primary Care and Specialty Settings

    Andrew D. Krystal, MD, MS, and Adam J. Sorscher, MD

    Watch this webcast to see 2 patient cases with different sleep difficulties. Listen as the faculty discuss these cases and give evaluation tools and treatment strategies that will help you manage patients with sleep problems in your own practice.

    View Activity

  • Tactics to Improve Adherence in Depressed Primary Care Patients

    C. Brendan Montano, MD

    Your patient's limited or nonresponse to antidepressant treatment may be hiding a deeper problem. Examine the case of Mr K to increase your knowledge regarding the significant issues that nonadherence may cause for patients diagnosed with MDD.

    View Activity


Most Popular


Improving the Care and Management of Patients With Inadequate Response to Depression Treatment

With only about one-third of patients with depression responding to their initial treatment trial, clinicians face the challenge of managing patients with poor response or treatment-resistant depression. In this Supplement, learn to identify difficult-to-treat types of depression, to select evidence-based treatments, to adjust treatment in a timely manner, and to coordinate care of comorbid conditions to improve patient outcomes.

>>See all Most Popular



Journal CME


Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients

Hitoshi Sakurai, MD; Takefumi Suzuki, MD, PhD; Robert R. Bies, PharmD; Bruce G. Pollock, MD, PhD, FRCPC; Masaru Mimura, MD, PhD; Shitij Kapur, MBBS, PhD; and Hiroyuki Uchida, MD, PhD

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out whether increasing the dose provides any greater benefit than waiting longer for patients to respond to the lower dose.

>>See entire activity

CME Partners

Enhancing Approaches to the Identification and Management of Pseudobulbar Affect

David W. Crumpacker, MD

Pseudobulbar affect has been unrecognized and untreated for too long. Check out this activity and watch its brief videos to learn about this embarrassing, socially limiting condition so you can better help your patients.

>> See entire activity